Open AccessLow-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
Author(s) -
Ming Zhang,
Liying Gao,
Xiaofeng Liu,
Fang Dong,
Qun Su,
Yanping Zhang,
Fengju Li,
Hulan Wang,
Pengbing Han
Publication year - 2022
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 90
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2022/3181133
Subject(s) - medicine , temozolomide , apatinib , adverse effect , chemotherapy , radiation therapy , incidence (geometry) , oncology , surgery , gastroenterology , optics , physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom